NPLS — NP Life Sciences Health Industry Balance Sheet
0.000.00%
Consumer DefensivesSpeculativeMicro Cap
Annual balance sheet for NP Life Sciences Health Industry, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.243 | 0.119 | 0.028 | 0.122 | 0.071 |
Prepaid Expenses | |||||
Total Current Assets | 0.243 | 0.119 | 0.038 | 0.128 | 0.077 |
Net Intangible Assets | |||||
Total Assets | 0.25 | 0.119 | 0.038 | 0.128 | 0.077 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.015 | 0.015 | 0 | 0.108 | 0.038 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.015 | 0.015 | 0 | 0.108 | 0.06 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.235 | 0.104 | 0.038 | 0.019 | 0.016 |
Total Liabilities & Shareholders' Equity | 0.25 | 0.119 | 0.038 | 0.128 | 0.077 |
Total Common Shares Outstanding |